Kazuoki Kondo, M.D.
Tanabe Pharma Corporation
8
0
7
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+8 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (8)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Nobuya Inagaki, M.D.
Kyoto University, Graduate School of Medicine
Shared therapeutic areas:
Worked with same sponsors:
Sabine Hazan, MD
ProgenaBiome
Shared therapeutic areas:
Kazuoki Kondo, MD
Tanabe Pharma Corporation
Shared therapeutic areas:
Worked with same sponsors:
Yu Nakamura, M.D., Ph.D.
Kagawa University School of Medicine
Shared therapeutic areas:
Worked with same sponsors:
Tadashi Yoshida, M.D.
Tanabe Pharma Corporation
Shared therapeutic areas:
Worked with same sponsors:
Takashi Kadowaki, M.D.
Tokyo University
Shared therapeutic areas:
Worked with same sponsors:
Paolo Bonato, PhD
Spaulding Rehabilitation Hospital
Shared therapeutic areas:
Olivier Beauchet, MD
Jewish General Hospital
Shared therapeutic areas:
Suman Wason, MD
Lexicon Pharmaceuticals, Inc.
Shared therapeutic areas:
Glen P Kenny, PhD
University of Ottawa
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (8)
Showing 8 of 8 trials
An Efficacy, Safety, and Tolerability Study for TA-7284 in Patients With Type 2 Diabetes
Long-Term Safety Study of TA-7284 in Patients With Type 2 Diabetes Mellitus
Efficacy and Safety Study of TA-7284 in Patients With Type 2 Diabetes
Efficacy and Safety of MP-424, Peginterferon Alfa-2a (PEG-IFN Alfa-2a), and Ribavirin(RBV) in Treatment-Naïve or Relapsed Hepatitis C
Efficacy and Safety of MP-424, Interferon Beta (IFN Beta), and Ribavirin(RBV) in Treatment-Naïve or Having Received Interferon Based Therapy With Chronic Hepatitis C (CHC)
Safety Study of MT-4666 in Subjects With Alzheimer's Disease
Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Teneligliptin)
All 8 trials loaded